Immunomatics

AI to reduce transplant rejection and save lives.

https://wefunder.com/immunomatics

Total raised on Wefunder: 78745

Total investors: 51

Quick facts

  • Founded by a stem cell transplant survivor with training in computational biology and AI
  • Awarded a $207,740 NIH Phase I SBIR grant, non-dilutive capital, & third-party scientific review
  • Tackling a major unmet need: roughly 1 in 5 kidney transplants fail within five years
  • Tackling GVHD and blood cancer relapse after blood stem cell transplants
  • AI rejection-risk scoring designed to optimize donor selection and personalize immunosuppression
  • Multidisciplinary team with relevant experience
  • Collaboration with UC San Diego's Immunogenetics & Transplantation Lab
  • Access to the U.S. solid organ transplant registry

Team profiles

Featured investor profiles

Invest in Immunomatics

AI to reduce transplant rejection and save lives

$80,055

of a $100,000 goal
INVESTMENT TERMS
Future Equity
$8M valuation cap 20% discount

What Investors Say

LEAD INVESTOR
Invested $5,000 this round
Immunomatics is exactly the kind of company I am excited to support—one that combines a technically strong founder, a significant medical need, and a data-driven approach with the potential to improve patient outcomes. Having previously worked closely with the founder, I have tremendous confidence in his scientific acumen and personal motivation. As a transplant patient himself, he experienced firsthand the challenges of possible transplant rejection/GVHD and gained a unique perspective on the limitations of current transplant matching. That combination of deep scientific insight, lived experience, and determination is incredibly compelling to me.
What People Say